Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs PolyPid Ltd. (PYPD)

Milestone Pharmaceuticals Inc. and PolyPid Ltd. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and PolyPid Ltd. are of similar size ($99.5M and $98.9M). PolyPid Ltd. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, PolyPid Ltd. leads on 8 and Milestone Pharmaceuticals Inc. on 4.

Valuation

Metric MIST PYPD Biotechnology median
P/E n/m n/m 8.50
P/S 18.59 n/m 9.71
P/B 5.41 19.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.16 n/m 0.64
EV/Sales (2.44) n/m 9.21
Earnings yield (97.18%) (31.16%) (33.15%)
Free cash flow yield (62.60%) (71.51%) (25.50%)

Profitability

Metric MIST PYPD Biotechnology median
Gross margin 13.27% — 65.16%
Operating margin (1,479.69%) 0.00% 0.00%
Net margin (1,586.01%) 0.00% 0.00%
Free cash flow margin (1,163.79%) 0.00% 0.00%
Return on equity (35,522.62%) (243.59%) (56.36%)
Return on assets (73.36%) (119.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MIST PYPD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (11.94%) 57.43% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIST PYPD Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 1.35 4.72
Net debt to EBITDA 0.79 0.39 0.96

Dividend

Metric MIST PYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MIST PYPD Biotechnology median
Market cap 98.91m 99.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack